Superior Vena Caval Obstruction (SVCO) - Management and Outcome

Superior Vena Cava Syndrome Clinical Trial

Official title: A Prospective Longitudinal Study of the Management and Outcome of Superior Vena Caval Obstruction (SVCO)

Status Completed

Clinical Trial Summary

All patients with symptomatic malignant SVCO deemed suitable for treatment either with radiation therapy or by stenting will be eligible. They will receive whichever treatment is deemed most clinically appropriate. Symptomatic response, time to onset of palliation, duration of symptom control and survival will be assessed.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Superior Vena Cava Syndrome

• NCT number: NCT00259584
• Study type: Interventional
• Source: University Health Network, Toronto
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: October 2001
• Completion date: October 2008